Skip to main content
Clinical Trials/NCT05058677
NCT05058677
Completed
Phase 4

Aerosolized Endotracheal Lidocaine to Avoid Intracranial Pressure Spikes in Patients With Severe Traumatic Brain Injury

The University of Texas Health Science Center, Houston1 site in 1 country10 target enrollmentNovember 9, 2021

Overview

Phase
Phase 4
Intervention
aerosolized 2% lidocaine (20mg/ml)
Conditions
Traumatic Brain Injury
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
10
Locations
1
Primary Endpoint
Maximum difference between baseline ICP and highest ICP levels as measured by the ICP monitor in instilled lidocaine versus nebulized lidocaine
Status
Completed
Last Updated
3 months ago

Overview

Brief Summary

The purpose of this study is to evaluate the effectiveness of nebulized lidocaine before Endotracheal suctioning (ETS) compared to instilled lidocaine and the effectiveness of aerosolized lidocaine versus instilled normal saline before ETS in attenuating the increase of intracranial pressure (ICP) in severe head injured children and to evaluate the feasibility of a trial involving instilled lidocaine and aerosolized lidocaine for the management of ETS and to evaluate the safety of nebulized lidocaine in traumatic brain injury (TBI) compared to instilled lidocaine and instilled sodium chloride (NS).

Registry
clinicaltrials.gov
Start Date
November 9, 2021
End Date
June 30, 2025
Last Updated
3 months ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Thao L Nguyen

Assistant Professor

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • Patients admitted to the PICU of Memorial Hermann Children's Hospital
  • Severe TBI with a Glasgow Coma Scale score 4-8
  • Intubated and mechanically ventilated with an ICP monitor in place.
  • Continuous invasive monitoring of arterial pressure
  • Hemodynamically Stable, defined by normal blood pressure for age before the ETS. We will not exclude patients with norepinephrine to maintain goal blood pressures to maintain Cerebral perfusion pressure(CPP).

Exclusion Criteria

  • Patients with sustained ICP \> 25 for more than 30 minutes mm Hg despite medical or neurosurgical intervention
  • Moderate/Severe Acute respiratory distress syndrome (ARDS) with an oxygenation index \> 8
  • Pulmonary hemorrhage
  • Patients receiving neuromuscular blockade
  • Use of other vasopressors for other causes of shock (cardiogenic, hypovolemic and septic)

Arms & Interventions

aerosolized lidocaine then Instilled lidocaine solution then instilled saline solution

Treatment will be performed before the endotracheal suctioning

Intervention: aerosolized 2% lidocaine (20mg/ml)

aerosolized lidocaine then Instilled lidocaine solution then instilled saline solution

Treatment will be performed before the endotracheal suctioning

Intervention: instilled 0.9% sodium chloride (NS)

aerosolized lidocaine then Instilled lidocaine solution then instilled saline solution

Treatment will be performed before the endotracheal suctioning

Intervention: instilled 2% lidocaine solution

aerosolized lidocaine then Instilled lidocaine solution then instilled saline solution

Treatment will be performed before the endotracheal suctioning

Intervention: Endotracheal Suctioning (ETS)

aerosolized lidocaine then instilled saline solution then Instilled lidocaine solution

Treatment will be performed before the endotracheal suctioning

Intervention: aerosolized 2% lidocaine (20mg/ml)

aerosolized lidocaine then instilled saline solution then Instilled lidocaine solution

Treatment will be performed before the endotracheal suctioning

Intervention: instilled 0.9% sodium chloride (NS)

aerosolized lidocaine then instilled saline solution then Instilled lidocaine solution

Treatment will be performed before the endotracheal suctioning

Intervention: instilled 2% lidocaine solution

aerosolized lidocaine then instilled saline solution then Instilled lidocaine solution

Treatment will be performed before the endotracheal suctioning

Intervention: Endotracheal Suctioning (ETS)

Instilled lidocaine solution then aerosolized lidocaine then instilled saline solution

Treatment will be performed before the endotracheal suctioning

Intervention: aerosolized 2% lidocaine (20mg/ml)

Instilled lidocaine solution then aerosolized lidocaine then instilled saline solution

Treatment will be performed before the endotracheal suctioning

Intervention: instilled 0.9% sodium chloride (NS)

Instilled lidocaine solution then aerosolized lidocaine then instilled saline solution

Treatment will be performed before the endotracheal suctioning

Intervention: instilled 2% lidocaine solution

Instilled lidocaine solution then aerosolized lidocaine then instilled saline solution

Treatment will be performed before the endotracheal suctioning

Intervention: Endotracheal Suctioning (ETS)

Instilled lidocaine solution then instilled saline solution then aerosolized lidocaine

Treatment will be performed before the endotracheal suctioning

Intervention: aerosolized 2% lidocaine (20mg/ml)

Instilled lidocaine solution then instilled saline solution then aerosolized lidocaine

Treatment will be performed before the endotracheal suctioning

Intervention: instilled 0.9% sodium chloride (NS)

Instilled lidocaine solution then instilled saline solution then aerosolized lidocaine

Treatment will be performed before the endotracheal suctioning

Intervention: instilled 2% lidocaine solution

Instilled lidocaine solution then instilled saline solution then aerosolized lidocaine

Treatment will be performed before the endotracheal suctioning

Intervention: Endotracheal Suctioning (ETS)

Instilled saline solution then aerosolized lidocaine then Instilled lidocaine solution

Treatment will be performed before the endotracheal suctioning

Intervention: aerosolized 2% lidocaine (20mg/ml)

Instilled saline solution then aerosolized lidocaine then Instilled lidocaine solution

Treatment will be performed before the endotracheal suctioning

Intervention: instilled 0.9% sodium chloride (NS)

Instilled saline solution then aerosolized lidocaine then Instilled lidocaine solution

Treatment will be performed before the endotracheal suctioning

Intervention: instilled 2% lidocaine solution

Instilled saline solution then aerosolized lidocaine then Instilled lidocaine solution

Treatment will be performed before the endotracheal suctioning

Intervention: Endotracheal Suctioning (ETS)

Instilled saline solution then Instilled lidocaine solution then aerosolized lidocaine

Treatment will be performed before the endotracheal suctioning

Intervention: aerosolized 2% lidocaine (20mg/ml)

Instilled saline solution then Instilled lidocaine solution then aerosolized lidocaine

Treatment will be performed before the endotracheal suctioning

Intervention: instilled 0.9% sodium chloride (NS)

Instilled saline solution then Instilled lidocaine solution then aerosolized lidocaine

Treatment will be performed before the endotracheal suctioning

Intervention: instilled 2% lidocaine solution

Instilled saline solution then Instilled lidocaine solution then aerosolized lidocaine

Treatment will be performed before the endotracheal suctioning

Intervention: Endotracheal Suctioning (ETS)

Outcomes

Primary Outcomes

Maximum difference between baseline ICP and highest ICP levels as measured by the ICP monitor in instilled lidocaine versus nebulized lidocaine

Time Frame: from baseline to upto 15 minutes after ETS

A Codman Intraparenchymal Catheter will measure the ICP.The ICP will be transduced and measured numerically and continuously in real time on the patient's bedside monitor.

Secondary Outcomes

  • Number of patients with worsening respiratory dynamics(from baseline to up to 15 minutes after ETS)
  • Maximum difference between baseline ICP and highest ICP levels as measured by the ICP monitor in nebulized lidocaine and normal saline(from baseline to up to 15 minutes after ETS)

Study Sites (1)

Loading locations...

Similar Trials